Correlation of platelet parameters with adverse maternal and neonatal outcomes in severe preeclampsia: A case-control

Benjamin S Umezuluike1, Chidebe C Anikwe1, Oluomachi C Nnachi2

  • 1Department of Obstetrics and Gynaecology, Alex Ekwueme Federal University Teaching Hospital, P.M.B 102 Abakaliki, Ebonyi state, Nigeria.

Heliyon
|December 17, 2021
PubMed

Insights

Platelet parameters like count and plateletcrit differ significantly in pre-eclampsia (PET). Increased platelet-large cell ratio (P-LCR) is a risk factor for eclampsia in PET patients.

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Perinatal Medicine

Background:

  • Pre-eclampsia (PET) is a serious pregnancy disorder characterized by oxidative stress, leading to endothelial damage and coagulopathy.
  • Platelet activation in PET contributes to inflammation, vasoconstriction, and adverse pregnancy outcomes.

Purpose of the Study:

  • To compare platelet indices between women with pre-eclampsia and normotensive pregnant women.
  • To investigate the relationship between platelet parameters and adverse outcomes in pre-eclamptic women.

Main Methods:

  • A case-control study involving 60 pre-eclamptic and 60 normotensive pregnant women.
  • Platelet indices were analyzed using a hematological auto-analyzer at recruitment and before delivery.
  • Statistical analysis was performed using IBM-SPSS version 22.

Main Results:

  • Significant differences were observed in mean platelet count, platelet distribution width (PDW), and plateletcrit between severe pre-eclamptic and normotensive groups.
  • Increased platelet-large cell ratio (P-LCR) was strongly associated with eclampsia.
  • Lower odds of abruptio placentae and preterm birth were noted at higher mean plateletcrit levels.

Conclusions:

  • Platelet count, plateletcrit, PDW, and P-LCR show significant differences between pre-eclamptic and normotensive women.
  • Elevated P-LCR is identified as a risk factor for eclampsia in pre-eclampsia.
Abstract